ATE336258T1 - Milchsäurebakterien und deren verwendungen zur behandlung von und vorbeugung gegen krebs - Google Patents

Milchsäurebakterien und deren verwendungen zur behandlung von und vorbeugung gegen krebs

Info

Publication number
ATE336258T1
ATE336258T1 AT02781021T AT02781021T ATE336258T1 AT E336258 T1 ATE336258 T1 AT E336258T1 AT 02781021 T AT02781021 T AT 02781021T AT 02781021 T AT02781021 T AT 02781021T AT E336258 T1 ATE336258 T1 AT E336258T1
Authority
AT
Austria
Prior art keywords
lactic acid
acid bacteria
treating
preventing cancer
cancer
Prior art date
Application number
AT02781021T
Other languages
English (en)
Inventor
Francois-Marie Luquet
Cindy Baldwin
Monique Lacroix
Original Assignee
Bio K Plus International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio K Plus International Inc filed Critical Bio K Plus International Inc
Application granted granted Critical
Publication of ATE336258T1 publication Critical patent/ATE336258T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT02781021T 2001-11-27 2002-11-27 Milchsäurebakterien und deren verwendungen zur behandlung von und vorbeugung gegen krebs ATE336258T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002364249A CA2364249A1 (fr) 2001-11-27 2001-11-27 Effet de bacteries lactiques sur l'apoptose cellulaire de tumeur

Publications (1)

Publication Number Publication Date
ATE336258T1 true ATE336258T1 (de) 2006-09-15

Family

ID=4170739

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02781021T ATE336258T1 (de) 2001-11-27 2002-11-27 Milchsäurebakterien und deren verwendungen zur behandlung von und vorbeugung gegen krebs

Country Status (9)

Country Link
US (1) US7887794B2 (de)
EP (1) EP1450832B1 (de)
AT (1) ATE336258T1 (de)
AU (1) AU2002349226A1 (de)
CA (1) CA2364249A1 (de)
DE (1) DE60214029T2 (de)
HK (1) HK1067985A1 (de)
MX (1) MXPA04005002A (de)
WO (1) WO2003045405A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2448843A1 (fr) 2003-11-13 2005-05-13 Bio-K Plus International Inc. Effets de differents surnageants de bacteries lactiques de bio-k plus sur des lignees cellulaires endotheliales
TW200700074A (en) 2005-03-04 2007-01-01 Calpis Co Ltd Inducer of t cell apoptosis
EP2015760A1 (de) * 2006-05-10 2009-01-21 Institut National de la Recherche Agronomique Verwendung von zellen, die ein spezifisches dns-molekül enthalten, als zytopathische mittel zur unterdrückung der zellproliferation
US20080124355A1 (en) 2006-09-22 2008-05-29 David Gordon Bermudes Live bacterial vaccines for viral infection prophylaxis or treatment
GB0624745D0 (en) * 2006-12-11 2007-01-17 Univ Sheffield Acetylation
KR20090092315A (ko) 2006-12-21 2009-08-31 칼피스가부시키가이샤 ＩｇＡ 생산 촉진제
US8241623B1 (en) 2009-02-09 2012-08-14 David Bermudes Protease sensitivity expression system
US8771669B1 (en) 2010-02-09 2014-07-08 David Gordon Bermudes Immunization and/or treatment of parasites and infectious agents by live bacteria
US8524220B1 (en) 2010-02-09 2013-09-03 David Gordon Bermudes Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria
US9597379B1 (en) 2010-02-09 2017-03-21 David Gordon Bermudes Protease inhibitor combination with therapeutic proteins including antibodies
FR2960001A1 (fr) * 2010-05-12 2011-11-18 Univ Rennes Vecteur recombinant pour la production et la secretion de sequences d'acides amines d'interet par les bacteries propioniques et ses applications
US9476056B2 (en) 2010-05-12 2016-10-25 Universite De Rennes 1 Recombinant vector for producing and secreting peptide or protein of interest by propionibacteria and applications thereof
KR20120015644A (ko) * 2010-08-12 2012-02-22 박진형 항암 활성을 갖는 락토바실러스 균주 및 이를 활성성분으로 포함하는 항암 활성 조성물
US9593339B1 (en) 2013-02-14 2017-03-14 David Gordon Bermudes Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
CN114028432A (zh) * 2021-11-05 2022-02-11 上海市第十人民医院 双歧杆菌提升铂类化疗药物敏感性的药物新用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69737420T2 (de) 1996-11-29 2007-11-15 Bio K + International Inc., Montreal Milchsaüreferment das ein spezieller stamm von lactobacillus acidophilus enthältund verwendung

Also Published As

Publication number Publication date
DE60214029T2 (de) 2007-03-29
MXPA04005002A (es) 2005-09-08
HK1067985A1 (en) 2005-04-22
DE60214029D1 (de) 2006-09-28
WO2003045405A2 (fr) 2003-06-05
US7887794B2 (en) 2011-02-15
EP1450832B1 (de) 2006-08-16
WO2003045405A3 (fr) 2003-10-09
CA2364249A1 (fr) 2003-05-27
US20050208033A1 (en) 2005-09-22
AU2002349226A1 (en) 2003-06-10
EP1450832A2 (de) 2004-09-01

Similar Documents

Publication Publication Date Title
HK1067985A1 (en) Lactic acid bacteria and their use for treating and preventing cancer
ATE302265T1 (de) Einen lactobacillus-stamm enthaltende zusammensetzung und verwendungen davon
TR200101699T2 (tr) Urogenital enfeksiyonların önlenmesi ve tedavisi için ağızdan lactobakilus uygulaması
MX2011012069A (es) Micro-organismos no-replicantes y su efecto inmuno estimulador.
BR0116349A (pt) Compostos probióticos derivados da cepa ke01 de lactobacillus casei
NZ593708A (en) Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin
ITMI20051509A1 (it) Ceppi di bifidobacterium produttori di acido folico loro formulazioni e uso
RU2010146956A (ru) Новый штамм lactobacillus paracasei subspecies paracasei, обладающий антимикробными и иммуномодулирующими свойствами
GB2465051A (en) Probiotic bifidobacterium strains
RU2010142489A (ru) Штамм lactobacillus rhamnosus
FI20001460A (fi) Probiootit atooppisten sairauksien primaariseen ehkäisyyn
GB2460781A (en) Probiotic bifidobacterium strains
UA94056C2 (uk) Застосування специфічних молочнокислих бактерій для одержання імуномодулюючих композицій
ATE354964T1 (de) Probiotische zusammensetzung mit mindestens zwei milchsäurebakterienstämmen, die zur kolonisierung des magen-darm-trakts fähig sind und in kombination damit die eigenschaften, im darm zu überleben, an den darm zu binden, gegen infektion zu schützen und ballaststoffe zu fermentieren, aufweisen
ATE425244T1 (de) Bifidobacteria zum vorbeugen von diarrhöe infolge pathogener bakterien
BRPI0511314A (pt) bactérias lácticas e seu uso na prevenção de diarréia
BR0008920A (pt) Cepas de lactobacillus capazes de prevenirdiarréia causada por bactéria patogênica erotaviroses
ATE442154T1 (de) Neues lactobacillus, den lebenden kírper aktivierende lactobacilluspräparation sowie präventivmittel oder therapeutikum gegen eine infektion des lebenden kírpers
MX2022008666A (es) Composicion probiotica para su uso como antioxidante.
BRPI0409609A (pt) mediadores do transporte reverso de colesterol para o tratamento da hipercolesterolemia
NO20014788L (no) Et materiale for å senke konsentrasjonen av patogene tarmpeptider
BR0012973B1 (pt) Uso de bactéria do ácido láctico pertencente ao gênero Bifidobacterium, e composição alimentícia ou farmacêutica.
DE602005001892D1 (de) Nutrazeutische Zusammensetzungen enthaltend Milchenzyme als Symbiose
ATE466023T1 (de) Mannose-spezifische adhesinen und deren vervendung
CR20230144A (es) Composiciones probióticas para el tratamiento del acné

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties